Sign in
4

Changes in Ownership

Prime Medicine, Inc. Filed Acc 0001894562-24-000048

Options or other derivatives

  • Chief Business Officer acquired 19,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Brudnick Richard Chief Business Officer 2024-12-05 Grant or award · Stock Option (right to buy) +19,300 57,900 D
Loading xslF345X05/wk-form4_1733786573.xml…